Alnylam Pharmaceuticals, Inc. (ALNY): Eastern Capital Owns 3.8 Million Shares

Page 3 of 8 SEC Filing
CUSIP No. 02043Q107 13G/A Page 3
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

PORTFOLIO SERVICES LTD.
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    ¨
(b)    ¨
3. SEC USE ONLY
 
4. CITIZENSHIP OR PLACE OF ORGANIZATION
 
CAYMAN ISLANDS
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER
 
0
6. SHARED VOTING POWER
 
 3,802,341
7. SOLE DISPOSITIVE POWER
 
0
8. SHARED DISPOSITIVE POWER
 
 3,802,341
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 3,802,341
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)    ¨
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

4.5%
12. TYPE OF REPORTING PERSON (see instructions)

CO

Follow Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)